Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis C Virus
Data on hepatitis C virus discussed by researchers at National Institutes of Health
November 26th, 2008
"Peripheral blood T-cell responses are used as biomarkers in hepatitis C virus (HCV) vaccine trials," scientists writing in the Journal of Virology report. "However, it is not clear how T-cell responses in the blood correlate with those in the liver, the infection site. By studying serial liver and blood samples of five vaccinated and five mock-vaccinated control chimpanzees during acute HCV infection, we demonstrate a correlation between HCV-specific CD8 T-cell responses in the blood and molecular and functional markers of T-cell responses in the liver," wrote E.C. Shin and colleagues, National Institutes of Health. The researchers concluded:...
Source: Vaccine Weekly (2008-11-26)
|
